Skip to content

News -

ISO IDMP is the next after xEVMPD

ISO IDMP is the next wave in the pharmacovigilance legislation after xEVMPD. But with a global scope and requiring data integration from the entire company it is a much bigger wave. In 2012, the five ISO standards referred to as "ISO IDMP" were approved. Their purpose is to standardise the identification of medicinal products, ultimately leading to improved pharmacovigilance across products, companies and jurisdictions. It has a global scope and in Europe for instance it will take effect by 2016.

2016 is by no means far away when planning to be compliant with ISO IDMP. Although the implementation guides and messaging standards for ISO IDMP are still to be seen, one thing is clear already: Being globally compliant with the ISO IDMP standards will require more than just an isolated solution. On the contrary, the entire IT landscape across the different divisions in the pharmaceutical company will have to be considered, and integration will have to be planned. Your IT strategy should plan for this already now.


Related links

Topics

Categories

Contacts

Lars B. Petersen

Press contact Senior Vice President Communications, Marketing & Commercial Excellence +45 3075 9102

Related content

Make the most of serialization

Change is afoot for pharmaceutical companies, with new serialisation legislation on the agenda. To help stem the problem of drug counterfeiting, they will be required to adopt a unique serial number labelling system and adapt their business processes accordingly. How can companies derive real business value from the investments they are now required to make?

Global Tracking Regulations Present Challenges and Benefits

Drug makers are facing an ever-increasing challenge as more countries implement serialization and tracking regulations and set compliance deadlines in an effort to ensure the safety and quality of prescription drugs being sold within their borders. Complying with regulations coming into effect will be a demanding task due to a lack of global harmonization.

Are you ready for ISO IDMP?

Are you ready for ISO IDMP?

Following the implementation of XEVMPD, new legislation, based on five new ISO IDMP standards, is due to come into force in 2016. Rune Ringsholm Bergendorff, advanced business consultant at NNIT, explains how pharmaceutical companies will need to adapt business processes across the whole organisation.

BI tool for smooth submission planning and execution

Regulatory approval for pharmaceutical products can be difficult to obtain, not least because the submission process is often slow and prone to errors. Thomas Svendsen and Peter Noes of NNIT tell World Pharmaceutical Frontiers how regulatory teams can use a business intelligence tool to monitor submission status and hasten time to market.

PSMF establishment and maintenance, business as usual?

Since the implementation of Directive 2010/84 and Regulation 1235/2010, marketing authorisation holders (MAHs) with products on the European market are obliged to maintain, and make available upon request, a Pharmacovigilance System Master File (PSMF).